Catalyst Wire Dossier Catalyst Wire Dossier

Anti-IL-5 monoclonal antibody

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-IL-5 monoclonal antibody, covering 2018-04-04 to 2018-04-04. Get the full timeline:

Most recent: Clinical Trial Update: Anti-Interleukin-5 (IL5) Monoclonal Antibody (MAb) in Prednisone-dependent Eosinophilic Asthma [Phase 2, Phase 3]

See pricing